Similar repopulating capacity of mitotically active and resting umbilical cord similar blood CD34 + cells in NOD/SCID mice

Blood

Volumn 96, Issue 6, 2000, Pages 2100-2107

  Wilpshaar, J ^a   Falkenburg, J H F ^a   Tong, X ^a   Noort, W A ^a   Breese, R ^a   Heilman, D ^a   Kanhai, H ^a   Orschell Traycoff, C M ^a   Srour, E F ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0034665896     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.6.2100.h8002100_2100_2107     Document Type: Article

References (49)

1. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells
2. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential
3. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis
4. Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow
5. Comparison of repopulating ability of hematopoietic progenitor cells isolated from human umbilical cord blood or bone marrow cells in NOD/SCID mice
6. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay
7. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow
8. In vivo engraftment potential of clinical hematopoietic grafts
9. CD34+ cells from umbilical cord blood, bone marrow and mobilized peripheral blood engraft differently in NOD/SCID mice
10. Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: An effect enhanced by cord blood plasma
11. Growth of human umbilical-cord blood in long-term haematopoietic cultures
12. Engraftment of bone marrow cells into normal unprepared hosts: Effects of 5-fluorouracil and cell cycle status
13. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells
14. Differentiation and proliferation of hematopoietic stem cells
15. Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123
16. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34+ cells in non-obese diabetic/severe combined immune-deficient mice
17. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice
18. Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0
19. Functional heterogeneity of human CD34+ cells isolated in subcompartments of the G0/G1 phase of the cell cycle
20. Assessment of proliferative and colony-forming capacity after successive in vitro divisions of single human CD34+ cells initially isolated in G0
21. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations
22. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells
23. Limiting dilution assays for the deterruination of immunocompetent cell frequencies. I. Data analysis
24. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice
25. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells
26. Stem cell quiescence/activation is reversible by serial transplantation and is independent of stromal cell genotype in mouse aggregation chimeras
27. Extrinsic control of stem cell fate: Practical considerations
28. Cell cycle analysis and synchronization of pluripotent hematopoietic progenitor stem cells
29. Ontogeny-related changes in proliferative potential of human hematopoietic cells
30. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of teleomeric DNA with age
31. Maintenance of transplantation potential in ex vivo expanded CD34+ selected human peripheral blood progenitor cells
32. Acomparison of long-term repopulating hematopoietic stem cells in fetal liver and adult bone marrow from the mouse
33. Different myelopoietic growth properties of human fetal and adult hematopoietic stem cells are associated with the absence of a functional inhibitory autocrine TGF-beta loop in fetal liver, but not in adult bone marrow
34. Transplantation of umbilical cord blood after myeloablarive therapy: Analysis of engraftment
35. Successful transplantation of HLA-matched and HLA-mismatched unbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease
36. Allogeneic umbilical cord blood transplantation
37. Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation
38. Purification of primitive human hematopoietic cells capable of repopulating immunodeficient mice
39. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
40. The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells
41. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture
42. Sustained proliferation, multi-lineage differentiation and maintenance of primitive human haematopoietic cells in NOD/SCID mice transplanted with human cord blood
43. Human growth factor-enhanced regeneration of transplantable human hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient mice
44. Mobilization of primitive hematopoietic progenitor cells into the periphery may involve their exit from the bone marrow microenvironment without entry into active phases of the cell cycle
45. Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors
46. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: Implications for stem cell frequency assessment
47. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
48. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into inmmunodeficient mice
49. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection